Rob Surgical has closed a €5 million investment round with the Dutch holding Scranton Enterprises to fund the final phase of the new Bitrack System and launched the product on the market. Osborne Clarke and RCD law firms provided advice throughout the process.
“This investment will allow us to obtain CE certification in 30 months? said Jaume Amat, CEO of Rob Surgical and president of CataloniaBio & HealthTech.